Cell Biotech Co Stock

Cell Biotech Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Cell Biotech Co (049960.KQ) as of Aug 4, 2026 is 8.47. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 4.88 — a change of 73.44% (higher).

P/CF

8.47

YoY

73.44%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Cell Biotech Co is 2026 8.47 . P/CF (Price-to-Cash-Flow Ratio) of Cell Biotech Co was 2025 4.88 . It decreases by 73.44% higher compared to the previous year.
Access this data via the Eulerpool API

Cell Biotech Co Stock analysis

What does Cell Biotech Co do? Cell Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cell Biotech Co stock

P/CF (Price-to-Cash-Flow Ratio) of Cell Biotech Co is 8.47 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Cell Biotech Co changed from 4.88 to 8.47, representing a 73.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Cell Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Cell Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Cell Biotech Co

All Key Metrics — Cell Biotech Co